Evidence map›Paper›PMID 41573912›Full record

ArticlebioRxiv : the preprint server for biology2025

Immune-cancer analyses across mammals reveal a potential trophic level and platelet-linked tradeoff between cancer and trauma mortality.

Stefania E Kapsetaki, Sareh Seyedi, Zachary T Compton, Shawn M Rupp, Elizabeth G Duke, Joshua D Schiffman, Brigid V Troan, Tara M Harrison, Carlo C Maley, Lisa M Abegglen and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefania E KapsetakiArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-9999-8573
Sareh SeyediArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0009-0006-3263-2055
Zachary T ComptonArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-0558-2316
Shawn M RuppArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.
Elizabeth G DukeArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-5534-0649
Joshua D SchiffmanArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-6968-7694
Brigid V TroanExotic Species Cancer Research Alliance, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0003-2212-2167
Tara M HarrisonArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-2072-5936
Carlo C MaleyArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-0745-7076
Lisa M AbegglenArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0003-3607-3001
Amy M BoddyArizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-7990-2415

Funding

PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Molecular, Cellular and Tissue Characterization UnitU2CCA233254 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY · 2018 to 2023
$11.4M
The Role of the Microbiome in Cancer Suppression and Susceptibility Across SpeciesU54CA217376 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MALEY, CARLO · 2018 to 2022
$8.6M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
T32 Cancer Prevention and Control Training Program Addressing Health DisparitiesT32CA272303 · NCI · UNIVERSITY OF ARIZONA · PI Terry A Badger, Gloria D. Coronado · 2023 to 2026
$1.1M
NCI NIH HHS P01 CA091955NCI NIH HHS R01 CA140657NCI NIH HHS T32 CA272303NCI NIH HHS U2C CA233254NCI NIH HHS U54 CA217376
6 · The paper itself

Abstract

There may be fitness tradeoffs between wound healing, immune responses, and cancer development due to shared pathways, limited resources and conflicting selective pressures. The immune system is important in both response to injury and carcinogenesis. We initially investigated correlations between cancer prevalence and immune cells, controlling for known associations with body mass and lifespan. We analyzed data from 216 mammalian species from at least 20 individuals per species. Body mass correlated positively with segmented neutrophil-to-lymphocyte ratios and negatively with lymphocyte concentrations. However, only platelet concentration correlated (negatively) with cancer prevalence (

Identifiers

PMID41573912
PMCPMC12822737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.